Acorda Therapeutics, Inc. (ACOR)

CAPS Rating:

A commercial-stage biopharmaceutical company dedicated to the identification, development & commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the CNS.

View All Commentary (ACOR)